Denovo Bio Technology is categorized under Commercial Biotechnical Research in Ijamsville, MD and active since 2011.
Denovo Bio Technology was established in 2011, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 3254140 by the NAICS.
If you are seeking more information, feel free to contact Scott Marsh at the company’s single location by writing to 9639 Doctor Perry Road, Ijamsville, Maryland MD 21754 or by phoning (301) 810-5327. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Denovo Bio Technology |
Contact Person: | Scott Marsh |
Address: | 9639 Doctor Perry Road, Ijamsville, Maryland 21754 |
Phone Number: | (301) 810-5327 |
Website Address: | virusys.com |
Annual Revenue (USD): | $5.000.000 to $9.999.999 |
Founded: | 2011 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Biotechnical Research |
SIC Code: | 8731 |
NAICS Code: | 3254140 |
Share This Business: |
Denovo Bio Technology was started in 2011 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 3254140. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Scott Marsh for inquiries that concern Denovo Bio Technology by calling the company number (301) 810-5327, as your correspondence is most welcome. Additionally, the physical location of the single location of Denovo Bio Technology can be found at the coordinates 39.29754,-77.33313 as well as the street address 9639 Doctor Perry Road in Ijamsville, Maryland 21754.
For its online presence, you may visit Denovo Bio Technology’s website at virusys.com and engage with its social media outlets through on Twitter and on Facebook.